The at-home FluMist vaccine will be for patients ages 2 to 49 years old. Patients can place an order online, complete a ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
Nasacort 24HR Allergy Nasal Spray is the first product Dr. Randolph Betts, MD, a family medicine practitioner based in California, recommends for nasal congestion. He notes that almost all his ...
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...
Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...